Aug 26 (Reuters) - Drug distributor McKesson (MCK.N), opens new tab said on Monday it would buy a controlling stake in community cancer center Florida Cancer Specialists & Research Institute's ...

McKesson, a drug distributor and medical-products company, will own a 70% stake in the company. Back To Top ...

An agreement between attorneys general and major drug distributors increased scrutiny on medications for A.D.H.D., addiction, anxiety and pain. By Christina Jewett and Ellen Gabler The case ...

McKesson Corp. agreed to buy a controlling stake in an arm of Florida Cancer Specialists & Research Institute, a privately held operator of clinics. Drug distributor McKesson will pay about $2.49 ...

Sales are also being positively impacted by increasing product pricing. In April, McKesson launched Project Oasis, an initiative aimed at advancing health equity for at-risk populations in ...

McKesson, a drug distributor and medical-products company, will own a 70% stake in the company. Core Ventures was set up by Florida Cancer Specialists & Research Institute, LLC, a physician-owned ...

Bloomberg News had reported last month that McKesson and rival drug distributors Cencora and Cardinal Health were vying to ...

McKesson Corp. is in advanced talks to buy a controlling stake in Florida Cancer Specialists & Research Institute, a privately-held operator of oncology clinics, according to people familiar with ...

McKesson said Monday it signed a definitive agreement to acquire a controlling stake in Community Oncology Revitalization Enterprise Ventures LLC, or Core Ventures, for $2.5 billion in cash.

McKesson (MCK) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

By joining The Network, FCS will have access to McKesson’s differentiated Oncology platform, including best-in-class oncology care products and services. “Above all else, our patients are the ...

Drug distributor McKesson may about $3.5 billion for Florida Cancer Specialists & Research Institute, according to a ...